senior notes offering Danaher Prices $1B Offering of Senior Notes Net proceeds from the offering are expected to be $984 million, which Danaher plans to use to redeem all outstanding 2.5 percent senior notes due in 2025. Thermo Fisher Scientific Prices €2.8B Senior Notes Offering The firm said it intends to use some of the proceeds to pay a portion of the cash consideration for its acquisition of clinical research services provider PPD. Thermo Fisher Scientific Prices $5.85B Senior Notes Offering The company said it intends to use the net proceeds to pay a portion of the cash consideration for its pending acquisition of clinical research services provider PPD. Thermo Fisher Scientific Prices €5.25B Notes Offering The company said it will use the proceeds from the offering to pay a portion of the cash consideration for its pending acquisition of PPD. PerkinElmer Prices Senior Notes Offering The $2.3 billion offering will provide some of the money PerkinElmer needs to complete its planned acquisition of BioLegend. Aug 10, 2021 Thermo Fisher Scientific Prices $3.1B Senior Notes Offering May 12, 2021 Sequencing Startup Singular Genomics Files for $100M IPO Mar 18, 2021 Illumina Prices $1B Senior Notes Offering Mar 4, 2021 PerkinElmer to Offer $800M in Senior Notes Mar 4, 2021 Agilent Prices $850M Senior Notes Offering Feb 10, 2021 Pacific Biosciences to Obtain $900M Investment From SoftBank Subsidiary Dec 3, 2020 Progenity Prices Separate Public Stock, Private Senior Notes Offerings Dec 1, 2020 Progenity to Raise $100M in Separate Public Stock, Private Senior Notes Offerings Nov 17, 2020 Guardant Health Prices $1B Senior Notes Offering Sep 30, 2020 Danaher Prices $1B Senior Notes Offering Sep 28, 2020 Hologic Completes $950M Senior Notes Offering Sep 15, 2020 Hologic Prices $950M Offering of Senior Notes Sep 14, 2020 Hologic Gets WHO Prequalification Approval for HIV Assay, Offers $950M in Senior Notes Jun 2, 2020 Agilent to Raise $500M Through Senior Notes Offering May 8, 2020 Luminex Prices $260M Senior Notes Offering Apr 30, 2020 NeoGenomics Aims to Raise $300M Through Common Stock, Senior Notes Offerings Apr 14, 2020 Natera Prices $250M Senior Notes Offering Apr 13, 2020 Natera Expects 35 Percent Rise in Q1 Revenues, Proposes $250M Senior Notes Offering Mar 30, 2020 Thermo Fisher Scientific Prices €1.2B Senior Notes Offering Mar 26, 2020 Danaher Prices €1.7 Billion Offering of Senior Notes Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more. Time to Act A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian. Fulgent Seeking Defamation Suit Fulgent Genetics says it plans to sue Los Angeles County Sheriff Alex Villanueva for defamation, the Los Angeles Times reports. Speeding Gene-Edited Crops Reuters reports that China's new trial rules will make it easier to grow gene-edited crops there.